BACIL PHARMA LTD.

Company Profile

BACIL PHARMA LTD. had its IPO on under the ticker symbol BACPHAR.

The company operates in the sector and industry. BACIL PHARMA LTD. has a staff strength of 0 employees.

Stock update

Shares of BACIL PHARMA LTD. opened at ₹6.51 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹6.51 - ₹6.55, and closed at ₹6.55.

This is a -4.38% slip from the previous day's closing price.

A total volume of 550 shares were traded at the close of the day’s session.

In the last one week, shares of BACIL PHARMA LTD. have slipped by -11.84%.

BACIL PHARMA LTD.'s Key Ratios

BACIL PHARMA LTD. has a market cap of ₹50.95 million, indicating a price to book ratio of 3.4835 and a price to sales ratio of 0.

In the last 12-months BACIL PHARMA LTD.’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures BACIL PHARMA LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BACIL PHARMA LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, BACIL PHARMA LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

BACIL PHARMA LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BACIL PHARMA LTD.’s profitability.

BACIL PHARMA LTD. stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.0203. Its price to sales ratio in the trailing 12-months stood at 0.

BACIL PHARMA LTD. stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹11.27 million

Total Liabilities

₹279000.00

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

BACIL PHARMA LTD. ended 2025 with ₹11.27 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹11.27 million while shareholder equity stood at ₹11.00 million.

BACIL PHARMA LTD. ended 2025 with ₹0 in deferred long-term liabilities, ₹279000.00 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹288000.00 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

BACIL PHARMA LTD.’s total current assets stands at ₹4.03 million while long-term investments were ₹0 and short-term investments were ₹3.65 million. Its net receivables were ₹0 compared to accounts payable of ₹4000.00 and inventory worth ₹0.

In 2025, BACIL PHARMA LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, BACIL PHARMA LTD. paid ₹0 in dividends in 2025.

Other key metrics

Current Trading Price

₹6.55

52-Week High

₹9.82

52-Week Low

₹3.85

Analyst Target Price

₹

BACIL PHARMA LTD. stock is currently trading at ₹6.55 per share. It touched a 52-week high of ₹9.82 and a 52-week low of ₹9.82. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹8.59 and 200-day moving average was ₹7.61 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.